Login
$AORT
$18.47 +$0.00 (0.0%) After hours

$AORT SEC Filings

Filed On Filing
06 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

ATLANTA, GA – (November 5, 2026) – Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced financial results for the third quarter ended September 30, 2026.

27 Oct 2026 SCHEDULE 13G/A
11 Sep 2026 Form 4: Green Andrew M, SVP, Regulatory and Quality

Sold 11,480 shares ($287K)

10 Sep 2026 144
04 Sep 2026 Form 4: Green Andrew M, SVP, Regulatory and Quality

Sold 6,510 shares ($177K) · Sold 1,493 shares ($38.8K)

03 Sep 2026 144
02 Sep 2026 144
27 Aug 2026 144
20 Aug 2026 Form 4: Mackin James P, President & CEO

Sold 70,000 shares ($2.03M)

19 Aug 2026 144
17 Aug 2026 Form 4: Green Andrew M, SVP, Regulatory and Quality

Sold 616 shares ($17.6K)

17 Aug 2026 Form 4: Berry Lance A, EVP, COO, CFO & Treasurer

Sold 715 shares ($20.4K)

14 Aug 2026 144
14 Aug 2026 144
14 Aug 2026 SCHEDULE 13G/A
12 Aug 2026 Form 4: Holloway Jean F, SVP, General Counsel

Sold 977 shares ($27.8K)

07 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition

ATLANTA, GA – (August 6, 2026) – Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced financial results for the second quarter ended June 30, 2026.

06 Aug 2026 SCHEDULE 13G/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support